Dynavax Technologies News

Dynavax Technologies Corporation today announced it has been awarded a $17 million contract to develop its advanced immunostimulatory sequences technology using Toll-Like Receptor 9 agonists as vaccine ...

OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, August 6th USMM, PODM, UDHC, MEDQ, DVAX 17:39 GMT Our Stocks to Watch today include U.S. Mine Makers Inc.

Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine ) Met its Primary Endpoint 2008-08-06 02:53:25 - www.dynavax.com - Dynavax Technologies Corporation and Merck & Co., ...

Dynavax Technologies Corp. and Novartis will work together on a "universal" flu vaccine developed by Dynavax.

Dynavax Technologies Corp. and Novartis will work together on a "universal" flu vaccine developed by Dynavax.

DVAX Stock Quote - Dynavax Technologies Corp Stock Quote - DVAX Quote - DVAX Stock Price Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp.

May 16, 2008 - Dynavax Technologies Corporation today reported primary endpoint data from a chamber study of TOLAMBA that showed a measurable clinical benefit, reducing total nasal symptom score by 41% vs. via Med Ad News

Inca Designs, Inc. announced today that the Company has chosen to convene on May 29, 2008 for a special meeting of the Board of Directors to vote on - 05/16/2008 - 07:00 AM SIMI VALLEY, Calif.-- --More than 70 ... via Business Wire

Shares of Livermore-based FormFactor dropped as much as 7 percent in morning trading after the maker of chip-testing equipment posted a wider-than-expected first-quarter loss of $18 million, or 37 cents a share ... via Inside Bay Area

San Francisco Business Times - by Steven E.F. Brown Money from a collaboration with Merck & Co. via Bizjournals

BERKELEY, Calif. & WHITEHOUSE STATION, N.J-- Dynavax Technologies Corporation and Merck & Co, Inc. via Med Ad News

Posted Wed Mar 19, 04:47 pm ET Posted By: Grant Zeng, CFA Dynavax Technologies Corporation is a biopharmaceutical company focused on drug development for the treatment and prevention of various infectious and ... via Zacks Analyst Blog

“These are issues we're going to have to address”

Executives of Dynavax Technologies Corp. and partner Merck & Co. Inc. have starting analyzing data after reports of a possible case of vasculitis in a single Phase III trial subject that prompted the FDA to put ... via BioWorld

The Food and Drug Administration put a "clinical hold" on testing of Dynavax Technologies Corp. via Bizjournals

The presentation will be webcast. To access the live audio broadcast and the subsequent archived audio recordings of the company presentation, please log onto the company's website at www.dynavax.com under the ... via PR-inside.com

Amgen, Inc. Dynavax Technologies today announced that Dr. Martin E. Sanders has been appointed Executive Vice President and Chief Development Officer. via Freshnews

Shares of Eli Lilly & Co. and Dynavax Technologies moved to higher ground early Friday as shares of most drugmakers moved lower or remained largely flat. via MarketWatch

Posted Wed Feb 20, 01:25 pm ET Posted By: Grant Zeng, CFA Dynavax Technologies Corporation is a biopharmaceutical company focused on drug development for the treatment and prevention of various infectious and ... via Zacks Analyst Blog

Dino Dina - President and Chief Executive Officer Deborah Smeltzer - Vice President, Operations and Chief Financial Officer Analysts Bret Holley - Oppenheimer & Company Katherine Xu - Credit Suisse Brian ... via Seeking Alpha